INTERSECT ENT (XENT) Covered Calls

INTERSECT ENT covered calls Intersect ENT Inc is a commercial stage drug-device company engaged in improving the life for patients with ear, nose and throat conditions.

You can sell covered calls on INTERSECT ENT to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for XENT (prices last updated Mon 4:16 PM ET):

INTERSECT ENT (XENT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
27.25 -0.25 27.05 27.45 411K - 0.8B
Covered Calls For INTERSECT ENT (XENT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Aug 17 27.5 0.15 27.30 0.5% 36.5%
Sep 21 27.5 1.40 26.05 5.4% 49.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Intersect ENT, Inc. is a commercial stage drug device company committed to improving the quality of life for patients with ear, nose and throat conditions. Its products, the PROPEL and PROPEL mini, are designed to improve the outcomes of sinus surgery by reducing postoperative inflammation and scarring from the underlying condition as well as the surgery. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.